Eric Raymond
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
-
- Esophageal Cancer Research and Treatment
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 1
- Ear and Head Tumors 1
- HER2/EGFR in Cancer Research 1
- Pancreatic and Hepatic Oncology Research 1
-
- Microtubule and mitosis dynamics 1
- Co-authors
- Eric Keith Rowinsky (1 shared paper)Daniel D. Von Hoff (1 shared paper)Gary M. Clark (1 shared paper)Elżbieta Izbicka (1 shared paper)Axel R. Hanauske (1 shared paper)Sandrine J. Faivre (2 shared papers)Olivier Hermine (1 shared paper)Jean‐François Seitz (2 shared papers)
In The Last Decade
Eric Raymond
4 papers receiving 311 citations
Eric Raymond's Hit Papers
Peers
Comparison fields: 5 of 46
- Oncology 122
- Surgery 121
- Pulmonary and Respiratory Medicine 54
- Biomaterials 23
- Immunology 24
Countries citing papers authored by Eric Raymond
This map shows the geographic impact of Eric Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Raymond more than expected).
Fields of papers citing papers by Eric Raymond
This network shows the impact of papers produced by Eric Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Raymond. The network helps show where Eric Raymond may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Raymond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study Hit paper breakdown → | 2023 | 210 |
| 2 | 2010 | 55 | |
| 3 | 1997 | 49 | |
| 4 | 2022 | 8 | |
| 5 | 2024 | 0 |
About Eric Raymond
Eric Raymond is a scholar working on Oncology, Cell Biology, Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology, having authored 5 papers that have together received 322 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (1 paper), Cancer Treatment and Pharmacology (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Ear and Head Tumors (1 paper), Neuroendocrine Tumor Research Advances (1 paper), HER2/EGFR in Cancer Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (122 citations), Surgery (121 citations), Pulmonary and Respiratory Medicine (54 citations), Biomaterials (23 citations) and Immunology (24 citations). Eric Raymond has collaborated with scholars based in France, Belgium and China. Frequent co-authors include Eric Keith Rowinsky, Daniel D. Von Hoff, Gary M. Clark, Elżbieta Izbicka, Axel R. Hanauske, Sandrine J. Faivre, Olivier Hermine, Jean‐François Seitz, Emmanuel Mitry and Jean‐Pierre Kinet. Their work appears in journals such as Anti-Cancer Drugs, Cancer Chemotherapy and Pharmacology, Therapeutic Advances in Medical Oncology, The Lancet Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.